Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Associated Banc-Corp
ASB
$6.12B
| $11.3M | 0.02% |
463,179
+140,279
| +43% | +$3.52M |
|
1152
Starwood Property Trust
STWD
$6.09B
| $11.3M | 0.02% |
+500,184
| New | +$11.3M |
|
|
FFIC
1153
DELISTED
Flushing Financial
FFIC
| $11.3M | 0.02% |
420,100
+23,500
| +6% | +$656K |
|
1154
Alarm.com
ALRM
$2.74B
| $11.3M | 0.02% |
367,000
+73,200
| +25% | +$2.13M |
|
|
TEN
1155
Tsakos Energy Navigation Ltd
TEN
$1.24B
| $11.3M | 0.02% |
471,040
-24,880
| -5% | -$591K |
|
1156
Gray Television
GTN
$518M
| $11.3M | 0.02% |
+777,350
| New | +$9.84M |
|
1157
Pearson
PSO
$9.71B
| $11.2M | 0.02% |
1,325,100
-220,300
| -14% | -$1.84M |
|
1158
Oshkosh
OSK
$9.47B
| $11.2M | 0.02% |
163,800
-941,000
| -85% | -$64.7M |
|
1159
Neogen
NEOG
$2.53B
| $11.2M | 0.02% |
456,267
+22,934
| +5% | +$561K |
|
|
CYBE
1160
DELISTED
Cyberoptics Corp
CYBE
| $11.2M | 0.02% |
431,600
-29,500
| -6% | -$947K |
|
|
UNVR
1161
DELISTED
Univar Solutions Inc.
UNVR
| $11.2M | 0.02% |
+365,200
| New | +$11M |
|
|
PTVCB
1162
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $11.2M | 0.02% |
456,900
+19,700
| +5% | +$473K |
|
|
GV
1163
DELISTED
Goldfield Corporation
GV
| $11.2M | 0.02% |
1,939,999
+310,400
| +19% | +$2.02M |
|
|
OMN
1164
DELISTED
OMNOVA Solutions Inc.
OMN
| $11.1M | 0.02% |
1,125,075
+52,300
| +5% | +$482K |
|
|
CBF
1165
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $11.1M | 0.02% |
255,813
-119,886
| -32% | -$4.83M |
|
1166
AXIS Capital
AXS
$7.3B
| $11.1M | 0.02% |
165,300
+54,200
| +49% | +$3.63M |
|
1167
Barrett Business Services
BBSI
$774M
| $11M | 0.02% |
806,740
+222,340
| +38% | +$3.32M |
|
1168
Ameris Bancorp
ABCB
$6B
| $11M | 0.02% |
238,883
-31,600
| -12% | -$1.44M |
|
1169
Anika Therapeutics
ANIK
$290M
| $11M | 0.02% |
253,100
+86,300
| +52% | +$4.12M |
|
1170
Imperial Oil
IMO
$62.7B
| $10.9M | 0.02% |
358,590
+352,495
| +5,783% | +$11.4M |
|
1171
UMB Financial
UMBF
$11.5B
| $10.9M | 0.02% |
144,900
+126,624
| +693% | +$9.69M |
|
|
BKI
1172
DELISTED
Black Knight, Inc. Common Stock
BKI
| $10.9M | 0.02% |
284,900
+186,000
| +188% | +$7M |
|
|
GWPH
1173
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10.9M | 0.02% |
+90,200
| New | +$11.1M |
|
1174
QuidelOrtho
QDEL
$1.01B
| $10.9M | 0.02% |
479,900
-22,300
| -4% | -$461K |
|
|
WPZ
1175
DELISTED
Williams Partners L.P.
WPZ
| $10.9M | 0.02% |
266,034
+600
| +0.2% | +$24.1K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.